Results 1 to 10 of about 12,420 (113)

Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome [PDF]

open access: yesLife, 2023
Most patients suffering from Lyme disease are effectively treated with antibiotics. In some patients, however, problems persist for a long time despite appropriate therapy.
Kristyna Sloupenska   +10 more
doaj   +4 more sources

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome [PDF]

open access: yesMicroorganisms, 2021
The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of ...
Kristyna Sloupenska   +9 more
doaj   +4 more sources

Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.

open access: yesInternational Journal of Infectious Diseases, 2022
Purpose: Post-treatment Lyme disease (PTLD) is characterized by patient-reported symptoms after treatment for Borrelia burgdorferi infection. The primary aim of this study was to assess whether participants with a history of Lyme disease (LD) would be ...
John N. Aucott   +5 more
doaj   +3 more sources

Antiphospholipid antibodies in acute and post-treatment Lyme disease [PDF]

open access: yesInfection and Immunity
Acute Lyme disease is caused by a Borrelia infection and typically responds to antibiotic treatment, but post-infectious chronic symptoms are common. The precise origin of these post-treatment symptoms is unknown; dysregulation of immune responses raised
Muskan Shrestha   +10 more
doaj   +2 more sources

Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease [PDF]

open access: yesFrontiers in Medicine, 2020
It has long been observed in clinical practice that a subset of patients with Lyme disease report a constellation of symptoms such as fatigue, cognitive difficulties, and musculoskeletal pain, which may last for a significant period of time.
Alison W. Rebman, John N. Aucott
doaj   +2 more sources

Neuroborreliosis and Post-Treatment Lyme Disease Syndrome: Focus on Children [PDF]

open access: yesLife, 2023
Neuroborreliosis is a form of Lyme Borreliosis (LB) that affects various structures of the central and peripheral nervous system. Although most cases of LB can be cured with a course of antibiotics, some children can present prolonged symptoms, which may
Agnieszka Myszkowska-Torz   +5 more
doaj   +2 more sources

Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome? [PDF]

open access: yesFrontiers in Neurology
Dysautonomia, or dysfunction of the autonomic nervous system (ANS), may occur following an infectious insult and can result in a variety of debilitating, widespread, and often poorly recognized symptoms.
Brittany L. Adler   +3 more
doaj   +2 more sources

Post-Treatment Lyme Disease Syndrome in Six European Countries Using Data from the Burden of Lyme Disease (BOLD) Study [PDF]

open access: yesPathogens
Up to 10% of patients with Lyme borreliosis (LB) will experience symptoms that fulfill the Infectious Disease Society of America (IDSA) criteria of post-treatment Lyme disease syndrome (PTLDS).
Holly Yu   +14 more
doaj   +2 more sources

Annexin A2 antibodies in post-treatment Lyme disease [PDF]

open access: yesTherapeutic Advances in Infectious Disease
Background: Anti-annexin A2 (AA2) antibodies have been described in Lyme arthritis and erythema migrans, although they have not been described in post-treatment Lyme disease (PTLD).
John B. Miller   +5 more
doaj   +2 more sources

Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review [PDF]

open access: yesAntibiotics, 2022
Lyme disease and associated co-infections are increasing worldwide and approximately 20% of individuals develop chronic Lyme disease (CLD)/Post-Treatment Lyme Disease Syndrome (PTLDS) despite early antibiotics.
Richard I. Horowitz, Phyllis R. Freeman
doaj   +2 more sources

Home - About - Disclaimer - Privacy